993 resultados para digital delay-line interpolation
Resumo:
Els formats de compressió amb pèrdua permeten elevades raons de compressió amb una qualitat de la imatge notable per a raons de compressió moderades. Aquesta memòria de recerca pretén valorar la influència de la compressió amb pèrdua sobre la classificació digital sobre dos tipus d’usos del sòl (forestal i agrícola) i en dues àrees de diferents nivells de fragmentació per a cada us del sòl. L’àrea classificada augmenta a nivells de compressió elevats, especialment usant el format JPEG. L’encert de la classificació disminueix a nivells de compressió elevades. En general el format JPEG2000 dóna millors resultats que JPEG.
Resumo:
Patrimoni Digital de Catalunya (PADICAT) es un proyecto de la Biblioteca Nacional de Catalunya iniciado en 2005. Éste consiste en capturar, procesar y dar acceso permanente a toda la producción cultural, científica y de carácter general catalana producida en formato digital. En definitiva, el objetivo de PADICAT es archivar el web catalán. Después de un año, se dispone de 2.400 capturas de más de 810 webs en 24 millones de ficheros (páginas HTML, imágenes…) que ocupan casi un terabyte de disco.
Resumo:
Conferencia presentada por el autor en el IX Congreso de la Asociación Española de Investigación Social Aplicada al Deporte (AEISAD), que tuvo lugar en Las Palmas de Gran Canaria del 16 al 18 de noviembre de 2006, analizando cómo los cambios en las nuevas tecnologías influencian la mutua relación entre medios y deporte.
Resumo:
En este proyecto se presenta una aplicación capaz de recibir la televisión digital y representar la información que contiene en un entorno de producción de gráficos tridimensionales. Esto conlleva recoger y procesar el flujo de transporte para más de un servicio, procesar las diferentes tablas de información, implementar mecanismos para representar la información audiovisual en un entorno tridimensional y construir una interfaz de usuario con los datos recogidos.
Resumo:
Entre 1998 y 1999, el Consorcio de Bibliotecas Universitarias de Cataluña (CBUC) creó una nueva línea de trabajo: la Biblioteca Digital de Cataluña. Ésta nació con la finalidad de contratar información electrónica interdisciplinar para la comunidad universitaria e investigadora de las bibliotecas miembro del Consorcio. Casi al mismo tiempo, esta línea de trabajo se amplió con la vertiente de la información propia generada por esta comunidad y se empezó a trabajar con la definición e implementación de repositorios electrónicos cooperativos. Estos últimos serán el objeto de este estudio. Se analiza su evolución, su estado actual, la estrategia para conseguir la inclusión de documentos (políticas institucionales, comités científicos, etc.), su contenedor (programas, tecnología usada, protocolos, etc.) y su contenido (estándares utilizados, derechos de autor, preservación, etc.). Por último se reflexiona sobre las ventajas, extraídas de la propia experiencia, de estos repositorios electrónicos cooperativos.
Resumo:
Entre 1998 i 1999, el Consorci de Biblioteques Universitàries de Catalunya (CBUC) va crear una nova línia de treball: la Biblioteca Digital de Catalunya. Aquesta va néixer amb la finalitat de contractar informació electrònica interdisciplinar per a la comunitat universitària i investigadora dels membres del Consorci. Gairebé al mateix temps, aquesta línia de treball es va ampliar amb la vessant de la informació pròpia generada per aquesta comunitat i es va començar a treballar amb la definició i implementació dels dipòsits electrònics cooperatius. Aquests últims seran l'objecte d'estudi. S'analitza la seva evolució, el seu estat actual, l'estratègia per aconseguir la inclusió de documents (polítiques institucionals, comitès científics, etc.), el seu continent (programes, tecnologia usada, protocols, etc.) i el seu contingut (estàndards utilitzats, drets d'autor, preservació, etc.). Per últim es reflexiona sobre les avantatges, extretes de la pròpia experiència, d'aquests dipòsits electrònics cooperatius.
Resumo:
E-repositories are part of the e-science, and they are based on the e-infrastructure. The Centre de Supercomputació de Catalunya (CESCA) together with the Consorci de Biblioteques Universitàries de Catalunya (CBUC) started in 1999 a cooperative repository, named TDR, to file, in digital format, the full-text of the read thesis at the universities of our country in order to spread them worldwide in open access, while at the same time, preserving the intellectual copyright of the authors. Since then, four additional cooperative repositories have been created: RECERCAT for research papers; RACO for scientific, cultural and erudite Catalan magazines; MDC for Catalan digital collections of pictures, maps, posters and old magazines; and PADICAT for archiving Catalan digital web content; The main objective of the latter is to archive Catalan web sites. That is, PADICAT collects, processes and provides permanent access to the entire cultural, scientific and general output of Catalonia in digital format. The repository manager is the Biblioteca de Catalunya, as the institution responsible for compiling, processing and distributing the bibliographic heritage of Catalonia, while CESCA is the technology partner. On September 11th, 2006 the repository went into operation for the general public, with some thirty websites archived. After one year and a half, it has 2.720 captures of more than 1.000 websites. This includes 34 million files (HTML, images...) and two terabytes of data. The objective of this paper is to present PADICAT and our experience developing and managing it.We describe the repository briefly, we explain the technology used to implement it and we comment our experiences during its first year and a half.
Resumo:
The combination of skin induration with clinical features such as dyspnea, facial telangiectasia, digital infarctions and/or dysphagia supports the diagnosis of systemic sclerosis. The oesophageal dysmotility is associated with symptoms which may delay the diagnosis of gastro-oesophageal cancer. Herein we report a case of long standing systemic sclerosis with heartburn and dysphagia symptoms which were monitored closely. Unfortunately, these symptoms delayed the diagnosis of gastric adenocarcinoma. This case prompted us to review the evidence of the association of cancer and systemic sclerosis and if any oncologic evaluation is required during the follow-up of patients affected with systemic sclerosis.
Resumo:
Amb freqüència s’associen les “Relacions Públiques” amb el “below the line”, qüestió que cal ser estudiada observant tant el punt de vista del propi sector de les relacions públiques com el del marketing i la comunicació publicitària, creadors aquests dos últims de la expressió i la categoria below the line. En plena “Era de la comunicació”, és imprescindible analitzar l’esmentada relació, tenint en compte el paper que juguen els nous mitjans emergents en el desenvolupament de les relacions públiques. Ens trobem en un nou entorn on desenvolupar aquesta professió únicament a través dels mitjans tradicionals poc té a veure amb la realitat del present. Avui les noves tecnologies i mitjans emergents ens porten a una “nova generació de la comunicació” on els professionals s’enfronten a nous conceptes que qüestionen l’antiga classificació de mitjans i disciplines above i below the line.
When the Line is Crossed... : Paths to Control and Sanction Behaviour Necessitating a State Reaction
Resumo:
The article presents a special form of a European comparative synopsis. For this case examples have been chosen ranging from administrative or minor (criminal) offences to increasingly serious offences and offenders. In this way it can be comparatively demonstrated how the criminal justice systems studied handle specific cases and whether they do so in a similar or different way.
Resumo:
Desde 1999 el Consorcio de Bibliotecas Universitarias de Cataluña (CBUC) ha creado una nueva línea de trabajo, junto con el Centro de Supercomputación de Cataluña (CESCA), para promocionar la investigación que se lleva a cabo en Cataluña y al mismo tiempo contribuir al movimiento mundial de depositar la producción académica y de investigación en la red de forma abierta. Este movimiento mundial, que recibe el nombre de Open Access, ha sido puesto en marcha con la finalidad de crear alternativas al paradigma de pagar por tener acceso a la información que se ha elaborado, muy a menudo, con financiación y recursos públicos. Esta nueva línea de trabajo son los depósitos institucionales. En esta comunicación presentamos brevemente el estado actual de los depósitos cooperativos implementados, su contenido (estándares usados, derechos de autor, preservación, etc.) y su continente (programas y tecnología utilizada, protocolos, etc.).
Resumo:
L'objectiu d'aquest estudi és presentar una investigació d'alt nivell sobre el contínuum físico-conceptual que ocupen tant les biblioteques digitals com les biblioteques físiques.
Resumo:
In 1903, the eastern slope of Turtle Mountain (Alberta) was affected by a 30 M m3-rockslide named Frank Slide that resulted in more than 70 casualties. Assuming that the main discontinuity sets, including bedding, control part of the slope morphology, the structural features of Turtle Mountain were investigated using a digital elevation model (DEM). Using new landscape analysis techniques, we have identified three main joint and fault sets. These results are in agreement with those sets identified through field observations. Landscape analysis techniques, using a DEM, confirm and refine the most recent geology model of the Frank Slide. The rockslide was initiated along bedding and a fault at the base of the slope and propagated up slope by a regressive process following a surface composed of pre-existing discontinuities. The DEM analysis also permits the identification of important geological structures along the 1903 slide scar. Based on the so called Sloping Local Base Level (SLBL) an estimation was made of the present unstable volumes in the main scar delimited by the cracks, and around the south area of the scar (South Peak). The SLBL is a method permitting a geometric interpretation of the failure surface based on a DEM. Finally we propose a failure mechanism permitting the progressive failure of the rock mass that considers gentle dipping wedges (30°). The prisms or wedges defined by two discontinuity sets permit the creation of a failure surface by progressive failure. Such structures are more commonly observed in recent rockslides. This method is efficient and is recommended as a preliminary analysis prior to field investigation.
Resumo:
The FIT trial was conducted to evaluate the safety and efficacy of 90Y-ibritumomab tiuxetan (0.4 mCi/kg; maximum dose 32 mCi) when used as consolidation of first complete or partial remission in patients with previously untreated, advanced-stage follicular lymphoma (FL). Patients were randomly assigned to either 90Y-ibritumomab treatment (n = 207) or observation (n = 202) within 3 months (mo) of completing initial induction therapy (chemotherapy only: 86%; rituximab in combination with chemotherapy: 14%). Response status prior to randomization did not differ between the groups: 52% complete response (CR)/CR unconfirmed (CRu) to induction therapy and 48% partial response (PR) in the 90Y-ibritumomab arm vs 53% CR/CRu and 44% PR in the control arm. The primary endpoint was progression-free survival (PFS) of the intent-to-treat (ITT) population. Results from the first extended follow-up after a median of 3.5 years revealed a significant improvement in PFS from the time of randomization with 90Y-ibritumomab consolidation compared with control (36.5 vs 13.3 mo, respectively; P < 0.0001; Morschhauser et al. JCO. 2008; 26:5156-5164). Here we report a median follow-up of 66.2 mo (5.5 years). Five-year PFS was 47% in the 90Y-ibritumomab group and 29% in the control group (hazard ratio (HR) = 0.51, 95% CI 0.39-0.65; P < 0.0001). Median PFS in the 90Y-ibritumomab group was 49 mo vs 14 mo in the control group. In patients achieving a CR/CRu after induction, 5-year PFS was 57% in the 90Y-ibritumomab group, and the median had not yet been reached at 92 months, compared with a 43% 5-year PFS in the control group and a median of 31 mo (HR = 0.61, 95% CI 0.42-0.89). For patients in PR after induction, the 5-year PFS was 38% in the 90Y-ibritumomab group with a median PFS of 30 mo vs 14% in the control group with a median PFS of 6 mo (HR = 0.38, 95% CI 0.27-0.53). Patients who had received rituximab as part of induction treatment had a 5-year PFS of 64% in the 90Y-ibritumomab group and 48% in the control group (HR = 0.66, 95% CI 0.30-1.47). For all patients, time to next treatment (as calculated from the date of randomization) differed significantly between both groups; median not reached at 99 mo in the 90Y-ibritumomab group vs 35 mo in the control group (P < 0.0001). The majority of patients received rituximab-containing regimens when treated after progression (63/82 [77%] in the 90Y-ibritumomab group and 102/122 [84%] in the control group). Overall response rate to second-line treatment was 79% in the 90Y-ibritumomab group (57% CR/CRu and 22% PR) vs 78% in the control arm (59% CR/CRu, 19% PR). Five-year overall survival was not significantly different between the groups; 93% and 89% in the 90Y-ibritumomab and control groups, respectively (P = 0.561). To date, 40 patients have died; 18 in the 90Y-ibritumomab group and 22 in the control group. Secondary malignancies were diagnosed in 16 patients in the 90Y-ibritumomab arm vs 9 patients in the control arm (P = 0.19). There were 6 (3%) cases of myelodysplastic syndrome (MDS)/acute myelogenous leukemia (AML) in the 90Y-ibritumomab arm vs 1 MDS in the control arm (P = 0.063). In conclusion, this extended follow-up of the FIT trial confirms the benefit of 90Y-ibritumomab consolidation with a nearly 3 year advantage in median PFS. A significant 5-year PFS improvement was confirmed for patients with a CR/CRu or a PR after induction. Effective rescue treatment with rituximab-containing regimens may explain the observed no difference in overall survival between both patient groups who were - for the greater part - rituximab-naïve.